View more in
Business

Despite bullying by Brussels, Pascal Soriot is turning AstraZeneca into a global powerhouse

Telegraph
 2021-06-04

A convoluted boardroom reshuffle at the top of AstraZeneca is likely to revive scrutiny of its highly ambitious £30bn swoop on US biotech firm Alexion. Marc Dunoyer, AstraZeneca’s finance chief of seven years, is stepping down to be replaced by his American counterpart Aradhana Sarin, but Dunoyer will stay on to become chief Astra’s chief strategy officer, as well as the new boss of Alexion, which will become the fulcrum of the company's rare disease arm.

www.telegraph.co.uk

Comments / 0

Comments / 0